Clinical trials
Completed Pulmonary Arterial Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
340 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 5 |
| 2004 | 6 |
| 2005 | 6 |
| 2006 | 12 |
| 2007 | 11 |
| 2008 | 16 |
| 2009 | 14 |
| 2010 | 30 |
| 2011 | 28 |
| 2012 | 17 |
| 2013 | 21 |
| 2014 | 12 |
| 2015 | 18 |
| 2016 | 12 |
| 2017 | 18 |
| 2018 | 23 |
| 2019 | 25 |
| 2020 | 7 |
| 2021 | 21 |
| 2022 | 11 |
| 2023 | 15 |
| 2024 | 7 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 340 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Actelion | 41 |
| United Therapeutics | 28 |
| Bayer | 18 |
| Bial - Portela C S.A. | 11 |
| GlaxoSmithKline | 8 |
| Mayo Clinic | 8 |
| Gilead Sciences | 7 |
| Merck Sharp & Dohme LLC | 6 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 6 |
| Assistance Publique - Hôpitaux de Paris | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Arterial Hypertension | 340 |
| Hypertension, Pulmonary | 87 |
| Familial Primary Pulmonary Hypertension | 13 |
| Lung Diseases, Interstitial | 8 |
| Hypertension | 7 |
| Lung Diseases | 7 |
| Connective Tissue Diseases | 6 |
| Heart Defects, Congenital | 6 |
| Scleroderma, Systemic | 6 |
| Cardiovascular Diseases | 5 |
Trials
Showing 76 to 100 of 340. Each trial links to its page on Pharma Observatory.
240 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.